Document is current
Any future updates will be listed below
-
Authors
Zhavoronkov, Alex https://orcid.org/0000-0001-7067-8966
Ivanenkov, Yan A.
Aliper, Alex
Veselov, Mark S.
Aladinskiy, Vladimir A.
Aladinskaya, Anastasiya V.
Terentiev, Victor A.
Polykovskiy, Daniil A.
Kuznetsov, Maksim D.
Asadulaev, Arip
Volkov, Yury
Zholus, Artem
Shayakhmetov, Rim R.
Zhebrak, Alexander
Minaeva, Lidiya I.
Zagribelnyy, Bogdan A.
Lee, Lennart H. https://orcid.org/0000-0002-7102-5446
Soll, Richard
Madge, David
Xing, Li
Guo, Tao https://orcid.org/0000-0001-6055-0985
Aspuru-Guzik, Alán
- License Information
-
More Information
Article History
Received: 1 November 2018
Accepted: 12 July 2019
First Online: 2 September 2019
Competing interests
: A. Zhavoronkov, Y.A.I., A. Aliper, M.S.V., V.A.A., A.V.A., V.A.T., D.A.P., M.D.K., A. Zholus, A. Asadulaev, Y.V., A. Zhebrak, R.R.S., L.I.M., and B.A.Z. work for Insilico Medicine, a commercial artificial intelligence company. L.H.L., R.S., D.M., L.X., and T.G. work for WuXi AppTec, a commercial research organization. A.A.-G. is a cofounder and board member of, and consultant for, Kebotix, an artificial intelligence-driven molecular discovery company and a member of the science advisory board of Insilico Medicine.
